Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.7072
+0.0012 (0.17%)
Apr 8, 2026, 4:00 PM EDT - Market closed
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $23.61 million as of April 8, 2026. Its market cap has decreased by -67.57% in one year.
Market Cap
23.61M
Enterprise Value
-1.86M
1-Year Change
-67.57%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $23.61M, a decrease of -93.37%. That is a compound annual growth rate of -74.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 23.60M | -1.67% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 24.51M |
| Plus Therapeutics | 24.43M |
| Boundless Bio | 24.20M |
| Neuphoria Therapeutics | 23.77M |
| Quantum BioPharma | 23.46M |
| Vistagen Therapeutics | 23.24M |
| Outlook Therapeutics | 22.91M |
| Tempest Therapeutics | 22.81M |